BlutdruckDaten & Medikamente
60
Quality Score
Solid
BlutdruckDaten & Medikamente
Low confidence
✍️ bumetric analysis
“
BlutdruckDaten & Medikamente is an iOS app from klier.net International S.L. in the Education category, currently rated 4.3★ across 29 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 60: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$200
per month
→
12-mo forecast
$100 – $931
per month
→
24-mo forecast
$100 – $2790
per month
MICRO tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$60K
↳ What it cost to build · not monthly revenue
Likely range $45K – $80K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Pays back in ~4 months at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Education complexity ×1.20 | +$10K |
Total estimate
$60K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$225K
↳ What it would sell for · not monthly revenue
Marketplace range $175K – $300K · 15× MRR multiple
💸
~3.8× return on build cost
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| 🏷 Education category multiple | +6% |
| ⭐ Small user base (<1K ratings) | -8% |
Final multiple
15× MRR
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$200/mo · ML-estimated from 234 triggers
Growth rate
+8.0% MoM · MICRO tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$127 – $508
12 months
$100 – $931
24 months
$100 – $2.8K
Compound growth at +8.0% MoM (tier baseline for MICRO). Range widens with horizon — typical noise band ±60% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Pre-traction · 42/100MICRO TIERminimal traction yetGrowth Velocity
5.0
Founder Strength
5.2
Product Quality
3.4
Revenue Strength
2.3
Monetization Maturity
1.0
Defensibility
6.0
Market Position
0.3
Operational Safety
10.0
- 💰 Revenue: Marginal — $0 - $500/mo · MICRO tier · indicative confidence, trajectory unclear.
- ⭐ Quality: 4.31★ across 29 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $3K-$6K. Portfolio play ($16K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 7 of 7 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| 5 starREVIEW | +$1,800 | |
| cancelledREVIEW | −$1,500 | |
| Mature app (15y old)METRIC | +$1,500 | |
| highly recommendREVIEW | +$1,400 | |
| Good rating (4.3★)METRIC | +$800 | |
| Pre-traction phase (29 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v8.3.2
This update from Apple will improve the functionality of this app. No new features are included.
The new version makes your charts interactive. You can now easily move the time range with your fingers as well as zoom in and out.… Full release notes →
The new version makes your charts interactive. You can now easily move the time range with your fingers as well as zoom in and out.… Full release notes →
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- BlutdruckDaten & Medikamente
- Developer
- klier.net International S.L.
- Bundle ID
- net.klier.blutdruck
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 4+
- Languages
- EN, DE
Company
- Website
- Not found
- Tagline
- Managing High Blood Pressure with the Digital Blood Pressure Pass
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $15.5K/mo
- Top-grossing rank
- 🇩🇪#7 /99
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
- Socials
- Not found
- info@bloodpressuredb.com
- Phone
- Not found
- Contact page
- bloodpressuredb.com/help.html
- About page
- Not found
📈Ratings growth29 ratings+2800% lifetimeShow 3-year history estimate ▾
Tracked (24 weeks) Pre-tracking estimate (37 weeks) · model-based, ±5% noise · anchored to release date and current value
🗺️Geographic Distribution1 of 9 markets
🇩🇪
DE
Top-grossing rank: #7 / 99
Other markets
Outside top 100
in US, GB, DE, FR, JP, CA, AU, BR, IN
in US, GB, DE, FR, JP, CA, AU, BR, IN
This app currently ranks in only one of the 9 markets we monitor. Niche or regional apps often launch this way before global rollout. Rankings update daily.
📊Category Rank Trajectory#7 now · best #1 · worst #8
Lower line = better rank · Estimate from ratings growth model · Lower position on chart = worse rank · Higher = top of chart
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
Recommended by doctors and pharmacists.
* Voted as Top Health App by doctors at HealthTap
* Recommended by the German association for kidney patients
* Gesundheit konkret: smart assistant - app-solute useful
* Top rating in iPad&Co.
* Top 5 medical App at appstar.tv
* Recommendation from the panel of experts at NummerSicher
Now you can have your blood pressure under control everywhere. Track, monitor and store your blood pressure (systolic and diastolic) along with your pulse, blood sugar and more.… View full description on the official store →
* Voted as Top Health App by doctors at HealthTap
* Recommended by the German association for kidney patients
* Gesundheit konkret: smart assistant - app-solute useful
* Top rating in iPad&Co.
* Top 5 medical App at appstar.tv
* Recommendation from the panel of experts at NummerSicher
Now you can have your blood pressure under control everywhere. Track, monitor and store your blood pressure (systolic and diastolic) along with your pulse, blood sugar and more.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 23 MB🔞 4+📱 iOS 12.0+🔖 v8.3.2🔄 updated 0d ago🌐 EN, DE📂 Education💰 Paid
📅
What Worked™ · Development Pipeline
9 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
🔄
Monetization changed: paid → free
2026-03
⭐
Rating ↑ 3.83 → 4.50 (improved 0.67★)
2026-03
📈
Crossed 50 ratings — social-proof flywheel kicking in
2017-03
📈
Crossed 10 ratings — social-proof flywheel kicking in
2016-01
⭐
Rating ↓ 4.29 → 3.88 (dropped 0.41★)
2013-08
⭐
Rating ↑ 3.33 → 3.75 (improved 0.42★)
2013-01
⭐
Rating ↓ 4.50 → 3.33 (dropped 1.17★)
2012-12
⭐
Rating ↓ 5.00 → 4.50 (dropped 0.50★)
2012-08
🚀
First tracked snapshot — initial data captured
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
More by klier.net International S.L.
View all →📦 Portfolio summaryINDIE studio
2apps·$16K/mocombined
⚠ Concentrated — top app contributes 95% of combined revenue (single-app dependency)
About this analysis
Why low confidence: only 29 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
📌 Final verdict — read this before you trust the numbers above
BlutdruckDaten & Medikamente is a small / niche iOS app in the education space with weak public traction — only 29 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does BlutdruckDaten & Medikamente make per month?▴
Our model estimates BlutdruckDaten & Medikamente earns roughly $15K/mo, but with only 29 ratings the confidence interval is wide. No founder-verified MRR is available for this app, so this is a model output calibrated against comparable apps in the same category. See methodology for the formula.
What apps are like BlutdruckDaten & Medikamente?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes BlutdruckDaten & Medikamente?▴
BlutdruckDaten & Medikamente is published by klier.net International S.L. on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is BlutdruckDaten & Medikamente's BU Score?▴
BlutdruckDaten & Medikamente has a BU Score of 60/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.